Education
About Us
Working with TipRanks
Follow Us
Wave Life Sciences Pte. Ltd (WVE)
:WVE
Total Valuation
Wave Life Sciences has a market cap or net worth of $1.34B. The enterprise value is $887.02M.
Market Cap$1.34B
Enterprise Value$887.02M
Share Statistics
Wave Life Sciences has 159,140,460 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding159,140,460
Owned by Insiders26.95%
Owned by Institutions0.08%
Financial Efficiency
Wave Life Sciences’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -44.36%.
Return on Equity (ROE)-0.46
Return on Assets (ROA)-0.28
Return on Invested Capital (ROIC)-44.36%
Return on Capital Employed (ROCE)-0.46
Revenue Per Employee377.36K
Profits Per Employee-338.01K
Employee Count287
Asset Turnover0.31
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Wave Life Sciences is ―. Wave Life Sciences’s PEG ratio is -0.60.
PE Ratio―
PS Ratio15.79
PB Ratio8.16
Price to Fair Value8.16
Price to FCF-11.26
Price to Operating Cash Flow-7.28
PEG Ratio-0.60
Income Statement
In the last 12 months, Wave Life Sciences had revenue of 108.30M and earned -97.01M in profits. Earnings per share was -0.70.
Revenue108.30M
Gross Profit108.30M
Operating Income-110.40M
Pretax Income-97.01M
Net Income-97.01M
EBITDA-101.74M
Earnings Per Share (EPS)-0.70
Cash Flow
In the last 12 months, operating cash flow was -199.18M and capital expenditures -940.00K, giving a free cash flow of -200.12M billion.
Operating Cash Flow-199.18M
Free Cash Flow-200.12M
Free Cash Flow per Share-1.26
Dividends & Yields
Wave Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.83
52-Week Price Change50.77%
50-Day Moving Average7.61
200-Day Moving Average9.90
Relative Strength Index (RSI)63.55
Average Volume (3m)1.59M
Important Dates
Wave Life Sciences upcoming earnings date is Nov 6, 2025, TBA (Confirmed).
Last Earnings DateJul 30, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date―
Financial Position
Wave Life Sciences as a current ratio of 2.89, with Debt / Equity ratio of 15.59%
Current Ratio2.89
Quick Ratio2.89
Debt to Market Cap0.00
Net Debt to EBITDA2.72
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Wave Life Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Wave Life Sciences EV to EBITDA ratio is -14.09, with an EV/FCF ratio of -9.44.
EV to Sales13.24
EV to EBITDA-14.09
EV to Free Cash Flow-9.44
EV to Operating Cash Flow-9.49
Balance Sheet
Wave Life Sciences has $208.48M in cash and marketable securities with $21.71M in debt, giving a net cash position of -$186.77M billion.
Cash & Marketable Securities$208.48M
Total Debt$21.71M
Net Cash-$186.77M
Net Cash Per Share-$1.17
Tangible Book Value Per Share$1.52
Margins
Gross margin is 90.74%, with operating margin of -101.94%, and net profit margin of -89.57%.
Gross Margin90.74%
Operating Margin-101.94%
Pretax Margin-89.57%
Net Profit Margin-89.57%
EBITDA Margin-93.94%
EBIT Margin-101.94%
Analyst Forecast
The average price target for Wave Life Sciences is $17.46, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$17.46
Price Target Upside99.32% Upside
Analyst ConsensusStrong Buy
Analyst Count14
Revenue Growth Forecast-14.98%
EPS Growth Forecast-51.76%